SRL
COLL icon

Scientech Research LLC’s Collegium Pharmaceutical COLL Stock Holding History

Scientech Research LLC’s Portfolio COLL Stock Details COLL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-12,434
Closed -$383K – 439
2023
Q4 		$383K Buy
+12,434
New +$311K 0.38% 65

Other funds holding COLL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Scientech Research LLC's COLL Position: Q1 2024 in Review

Scientech Research LLC sold out of Collegium Pharmaceutical (COLL) in Q1 2024, closing a stake of 12,434 shares — an estimated $383K sold.

Scientech Research LLC first reported a position in COLL in Q4 2023 and held it in 1 quarter. The position peaked at $383K in Q4 2023. 228 funds tracked by Wall St. Rank hold COLL as of Q1 2024.

  • Scientech Research LLC reported no remaining Collegium Pharmaceutical position as of Q1 2024 after selling out during the quarter.
  • Scientech Research LLC sold 12,434 Collegium Pharmaceutical shares in Q1 2024, an estimated $383K.
  • Scientech Research LLC first reported a position in Collegium Pharmaceutical in Q4 2023 and held it in 1 quarter.
  • Scientech Research LLC's Collegium Pharmaceutical position peaked at $383K in Q4 2023.
  • 228 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q1 2024.

Based on Scientech Research LLC's 13F filing for Q1 2024, filed 15 May 2024.